Transjugular intrahepatic portosystemic shunt in the therapy of refractory ascites: single center point of view
2014
Abstract
Ascites and refractory ascites is one of the most severe complications of portal hypertension and is associated with high mortality. When ascites becomes refractory, liver transplantation, large volume paracentesis with albumin substitution or nonsurgical portocaval shunt creation - transjugular intrahepatic postosystemic shunt (TIPS), are the treatment options.
The role of TIPS is still discussed. Temporary view on TIPS role in the therapy of refractory ascites and own experience with the treatment of 361 patients by TIPS in the last 22 years are referred to.